Hisashi Yokomizo
7PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 07, 2025
Liver function effects of SGLT2 inhibitor and GLP-1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study).Daisuke Tsuriya, Kazuo Kobayashi, Kei Takeshita
|Apr 01, 2025
Relationship of dietary intake and eating behaviors with glycemic control and body weight under long-term treatment with dapagliflozin: an exploratory prospective study.Hisashi Yokomizo, Daiji Kawanami, Noriyuki Sonoda
|May 20, 2024
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.Shunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda
|Jun 01, 2022
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis.Kyoungmin Park, Qian Li, Matthew D Lynes
|Jan 20, 2022
Differential effect of canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice.Hiroko Otsuka, Hisashi Yokomizo, Shintaro Nakamura
|Sep 29, 2019
Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes.Qian Li, Jialin Fu, Yu Xia
Pageof 2
Frequent Collaborators
2 joint publications
I-Hsien Wu
2 joint publications
Sayaka Katagiri
2 joint publications
Kazuo Kobayashi
2 joint publications
George L King
1 joint publications
Yasutaka Maeda
1 joint publications
Sonia L Hernandez
1 joint publications
Ward Fickweiler
1 joint publications
Bei Sun
1 joint publications
Daiji Kawanami
1 joint publications
Timothy S Kern
